These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men. Bagatell CJ, McLachlan RI, de Kretser DM, Burger HG, Vale WW, Rivier JE, Bremner WJ. J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592 [Abstract] [Full Text] [Related]
11. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen. Bhasin S, Yuan QX, Steiner BS, Swerdloff RS. J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307 [Abstract] [Full Text] [Related]
12. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive. Bremner WJ, Bagatell CJ, Steiner RA. J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925 [Abstract] [Full Text] [Related]
13. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA, Wallace AM, Wu FC. J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [Abstract] [Full Text] [Related]
16. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C. Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551 [Abstract] [Full Text] [Related]
17. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. Anderson RA, Wu FC. J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547 [Abstract] [Full Text] [Related]
18. Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men. Jockenhövel F, Bhasin S, Steiner BS, Rivier JE, Vale WW, Swerdloff RS. J Clin Endocrinol Metab; 1988 May; 66(5):1065-70. PubMed ID: 3129447 [Abstract] [Full Text] [Related]